LiveCare, Inc.

LiveCare, Inc.

LVCE
LiveCare, Inc.US flagOther OTC
0.01
USD
- -
- -
357,224.00Market Cap
LiveCare, Inc.
LVCE
(Other OTC)

Recent

price

0.01

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
LiveCare, Inc. (LVCE) operates as a telehealth and remote patient monitoring company focused on chronic disease management, particularly type II diabetes, through real-time analytics, health coaching, and personalized support services; its core offerings include state-of-the-art cellular glucometers with testing strips and lancets, Bluetooth-enabled blood pressure cuffs for hypertension and congestive heart failure patients, 24/7 monitoring platforms, certified diabetes educators, nutrition guides, telemedicine consultations, and emergency response coordination, all covered by Medicare and select insurances for seniors seeking independent living. Founded in March 2018 and headquartered at 1500 East Venice Avenue, Suite 411, Venice, Florida, the company serves patients across multiple U.S. states including Alabama, Arizona, California, Colorado, Florida, Georgia, Texas, Ohio, and others, employing doctors, nurses, dietitians, physical therapists, and ADCES-certified health coaches to reduce hospital readmissions and healthcare costs. Recent developments encompass rapid patient acquisitions surpassing 68 new enrollments in single days during 2024, expansion into hypertension monitoring with new blood pressure technology, strategic state service growth announced in late 2023 and early 2024, a broker-dealer agreement with Glendale Securities for improved liquidity executed in early 2024, and revenue milestones positioning toward profitability and NASDAQ aspirations amid projections for 26,000 patients by end-2025.

Company News

APIChatGPT
  • LiveCare Inc. Announces Resolution of Investigation with the U.S. Department of Justice After Proactive Self-Disclosure

  • LiveCare Inc. (OTCMKTS: LVCE) Marks Monumental Revenue Milestone Setting Eyes on Profitability

  • LiveCare Inc. (OTCMKTS: LVCE) Experiences Unprecedented Growth and Technological Advancements Post-Revamp

  • LiveCare Inc's (OTCMKTS: LVCE) Blood Pressure Cuff Sets New Standards in Healthcare, Fueling Remarkable Growth and Patient Adoption

  • LiveCare Inc.(OTCMKTS: LVCE) Enters Hypertension Market, Enhancing Healthcare Monitoring for U.S. Adults

  • LiveCare Inc. (OTCMKTS: LVCE) Announces Stellar Revenue Growth, Strategic Patient Expansion in Telehealth for Diabetes Care, and Aspirations for NASDAQ Listing

  • LiveCare Inc. Commemorates Patient Acquisition Milestone and Entrance to Additional Market

  • LiveCare Inc. Expands Telehealth Services Across Multiple States, Welcomes Dr. Nina Patel, and Celebrates Patient Acquisition Milestones

  • LiveCare Inc. Ushers in a New Era of Telehealth in Dubai with Historic Licensing Achievement

  • LiveCare Continues Rapid Growth and Expansion into Key States

  • LiveCare Celebrates Remarkable Growth in Daily Member Acquisitions

  • LiveCare Adds Texas and Ohio to Its State Expansion Initiative

  • LiveCare Announces Middle East Expansion Initiative

  • LiveCare's Member Acquisition Surges With In-House Program